Share Twitter LinkedIn Facebook Email Sen Zhuang, MD, PhD, VP, Oncology Clinical Research, Janssen, discusses The Development Of LCAR-B38M. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Immunotherapy Side Effects Under Scrutiny: New Data on Bone Density and T-Cell Insights AACR 3 Mins Read
Immunotherapy Revolution Unveiled: How TLS-Derived Antibodies Are Changing Cancer Treatment AACR Io 2025 AACR 4 Mins Read
AACR IO 2025: Revolutionary Insights into Desmoplastic Melanoma Treatment – Kari L Kendra, MD, PHD AACR 5 Mins Read
